BRPI0912175A2 - métodos para diagnosticar indução de enzima do fígado, para determinar se um composto é capaz de induzir indução de enzima do fígado em um indivíduo, e para identificar uma substância para tratar indução de enzima do fígado - Google Patents
métodos para diagnosticar indução de enzima do fígado, para determinar se um composto é capaz de induzir indução de enzima do fígado em um indivíduo, e para identificar uma substância para tratar indução de enzima do fígadoInfo
- Publication number
- BRPI0912175A2 BRPI0912175A2 BRPI0912175A BRPI0912175A BRPI0912175A2 BR PI0912175 A2 BRPI0912175 A2 BR PI0912175A2 BR PI0912175 A BRPI0912175 A BR PI0912175A BR PI0912175 A BRPI0912175 A BR PI0912175A BR PI0912175 A2 BRPI0912175 A2 BR PI0912175A2
- Authority
- BR
- Brazil
- Prior art keywords
- liver enzyme
- enzyme induction
- identify
- substance
- individual
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08157077 | 2008-05-28 | ||
EP09151546 | 2009-01-28 | ||
PCT/EP2009/056312 WO2009153131A1 (en) | 2008-05-28 | 2009-05-25 | Means and methods for assessing liver enzyme induction |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0912175A2 true BRPI0912175A2 (pt) | 2015-10-06 |
Family
ID=41151807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0912175A BRPI0912175A2 (pt) | 2008-05-28 | 2009-05-25 | métodos para diagnosticar indução de enzima do fígado, para determinar se um composto é capaz de induzir indução de enzima do fígado em um indivíduo, e para identificar uma substância para tratar indução de enzima do fígado |
Country Status (9)
Country | Link |
---|---|
US (1) | US8808979B2 (pt) |
EP (1) | EP2286235A1 (pt) |
JP (2) | JP2011522231A (pt) |
CN (1) | CN102105793A (pt) |
AU (1) | AU2009259535B2 (pt) |
BR (1) | BRPI0912175A2 (pt) |
CA (1) | CA2724512A1 (pt) |
DE (1) | DE112009001245T5 (pt) |
WO (1) | WO2009153131A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2529235B1 (en) | 2010-01-29 | 2019-03-06 | Metanomics GmbH | Means and methods for diagnosing heart failure in a subject |
JP5837581B2 (ja) * | 2010-06-10 | 2015-12-24 | メタノミクス ヘルス ゲーエムベーハー | 肝疾患を診断する方法 |
WO2022187228A1 (en) * | 2021-03-01 | 2022-09-09 | Board Of Regents, The University Of Texas System | Methods of detecting advanced liver fibrosis or hepatocellular carcinoma biomarkers in a sample |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4540884A (en) | 1982-12-29 | 1985-09-10 | Finnigan Corporation | Method of mass analyzing a sample by use of a quadrupole ion trap |
US5397894A (en) | 1993-05-28 | 1995-03-14 | Varian Associates, Inc. | Method of high mass resolution scanning of an ion trap mass spectrometer |
GB9519490D0 (en) * | 1995-09-25 | 1995-11-29 | Melvin William T | Use of a cytochrome P450 enzyme in tumour cells as a marker and target |
EP2462932A1 (en) * | 2002-01-07 | 2012-06-13 | Board Of Regents, The University Of Texas System | S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer |
AU2003219713A1 (en) * | 2002-02-04 | 2003-09-02 | Gene Logic, Inc. | Primary rat hepatocyte toxicity modeling |
JP2003304888A (ja) * | 2002-03-14 | 2003-10-28 | F Hoffmann La Roche Ag | 化合物の毒性予測のための方法 |
CN1627955A (zh) * | 2002-03-26 | 2005-06-15 | 科学与工业研究委员会 | 余甘子对与细胞色素p-450有关的肝毒性的治疗作用 |
WO2005034876A2 (en) * | 2003-10-10 | 2005-04-21 | Multicell Technologies, Inc. | Use of cell lines to produce active therapeutic proteins |
WO2005109006A1 (ja) * | 2004-04-23 | 2005-11-17 | Ajinomoto Co., Inc. | 非アルコール性脂肪肝炎鑑別方法 |
US7645584B2 (en) * | 2005-04-01 | 2010-01-12 | University Of Florida Research Foundation, Inc. | Biomarkers of liver injury |
DE602006013465D1 (de) | 2005-07-25 | 2010-05-20 | Basf Se | Verfahren zur bereitstellung und analyse einer tierpopulation mit im wesentlichem identischem metabolom |
EP1996718B1 (en) * | 2006-03-06 | 2011-11-30 | Ceetox Inc. | Toxicity screening methods |
CA2647122A1 (en) * | 2006-03-24 | 2007-10-04 | Metanomics Gmbh | Means and method for diagnosing diabetes |
EP1837657A1 (en) * | 2006-03-24 | 2007-09-26 | Metanomics GmbH | Means and method for predicting or diagnosing diabetes |
ATE536425T1 (de) * | 2006-10-13 | 2011-12-15 | Metabolon Inc | Mit metabolischem alter verbundene biomarker und verfahren zur verwendung davon |
WO2009036376A1 (en) * | 2007-09-13 | 2009-03-19 | University Of Hawaii | Fatty acid markers for the diagnosis, prognosis and management of cardiovascular disease |
WO2009059150A2 (en) * | 2007-11-02 | 2009-05-07 | Metabolon, Inc. | Biomarkers for fatty liver disease and methods using the same |
EP2286236B1 (en) * | 2008-05-28 | 2016-04-20 | Basf Se | Methods for assessing liver toxicity |
EP2157431A1 (en) * | 2008-08-11 | 2010-02-24 | One Way Liver Genomics, S.L. | Method for the diagnosis of NASH using metabolic profiles |
US8658353B2 (en) * | 2008-11-25 | 2014-02-25 | Corning Incorporated | Liver cell toxicity assay |
-
2009
- 2009-05-25 CA CA2724512A patent/CA2724512A1/en not_active Abandoned
- 2009-05-25 BR BRPI0912175A patent/BRPI0912175A2/pt not_active IP Right Cessation
- 2009-05-25 US US12/994,655 patent/US8808979B2/en not_active Expired - Fee Related
- 2009-05-25 DE DE112009001245T patent/DE112009001245T5/de not_active Withdrawn
- 2009-05-25 JP JP2011510975A patent/JP2011522231A/ja active Pending
- 2009-05-25 AU AU2009259535A patent/AU2009259535B2/en not_active Ceased
- 2009-05-25 EP EP09765711A patent/EP2286235A1/en not_active Withdrawn
- 2009-05-25 CN CN200980129418XA patent/CN102105793A/zh active Pending
- 2009-05-25 WO PCT/EP2009/056312 patent/WO2009153131A1/en active Application Filing
-
2014
- 2014-10-10 JP JP2014208554A patent/JP2015042985A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2015042985A (ja) | 2015-03-05 |
US8808979B2 (en) | 2014-08-19 |
AU2009259535B2 (en) | 2016-01-21 |
AU2009259535A8 (en) | 2011-02-03 |
AU2009259535A1 (en) | 2009-12-23 |
CA2724512A1 (en) | 2009-12-23 |
WO2009153131A1 (en) | 2009-12-23 |
JP2011522231A (ja) | 2011-07-28 |
EP2286235A1 (en) | 2011-02-23 |
US20110091929A1 (en) | 2011-04-21 |
DE112009001245T5 (de) | 2012-03-15 |
CN102105793A (zh) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0912110A2 (pt) | métodos para diagnosticar a toxicidade do fígado, para determinar se um composto é capaz de induzir a toxicidade no fígado em um indivíduo, e para identificar uma substância para tratar toxicidade do fígado | |
SMT201700037B (it) | Nuovi inibitori pirrolici della s-nitrosoglutatione riduttasi come agenti terapeutici | |
FI20086085A (fi) | Menetelmä ja laite resurssien virtualisoimiseksi | |
BR112012001325A2 (pt) | tratamento de distúrbios do fígado com inibidaores de pi3k | |
BRPI0920498A2 (pt) | método de tratamento de uma condição em um sujeito | |
BRPI0920054A2 (pt) | execução em modo seguro de plug-ins | |
BRPI0913165A2 (pt) | método para detectar malware em dispositivos de computação | |
BRPI0920670A2 (pt) | composição nutritiva para promover o desenvolvimento e crescimento sadios | |
BRPI0909672A2 (pt) | detecção de moléculas específicas para hepatocarcinoma | |
BR112013012485A2 (pt) | método de tratamento com inibidor braf | |
BR112014007267A2 (pt) | kit para otimizar o desempenho de usuário em uma atividade, conjunto de dois kits e método para seleção de um aparelho oral para o kit | |
BRPI0913398A2 (pt) | composição e métodos de adesivo para dentaduras | |
BRPI0916157A2 (pt) | método para tingir fibras queratinosas e kit para implementação do dito método para tingir fibras queratinosas | |
BRPI0921804A2 (pt) | método assistido por computador apropriado para auxiliar no projeto de uma aeronave | |
BR112013012360A2 (pt) | métodos para conferir uma imagem a uma superfície e kits para usar com eles | |
BR112012015266A2 (pt) | dispositivo configurado para receber uma amostra e método para determinar a presença de um analito em uma amostra | |
DE112009001910A5 (de) | Sleep determination and sleep determination method | |
BR112012003584A2 (pt) | método e disposito para utilização de biomassa | |
BR112013013288A2 (pt) | método, reagente e kit para medir um componente a ser medido em uma amostra, e, método para suprimir a influência de um peróxido sobre o dito método | |
BRPI0912175A2 (pt) | métodos para diagnosticar indução de enzima do fígado, para determinar se um composto é capaz de induzir indução de enzima do fígado em um indivíduo, e para identificar uma substância para tratar indução de enzima do fígado | |
EE201100051A (et) | Meetod ja testssteem B-kompleksi vitamiinide aktiivsuse samaaegseks kvantitatiivseks mramiseks toidus | |
BR112012015013A2 (pt) | Composição de carne e método de uso de óleo de soja | |
BRPI0919987A2 (pt) | dispositivo biosensor magnético e método para aplicar um campo magnético em uma superfície do sensor de um dispositivo biosensor magnético | |
BRPI0923149A2 (pt) | uso dos compostos a e b em uma composição poliolefínica para aumentar a vida útil de um duto | |
BR112013012593A2 (pt) | métodos e composições para detectar uma atividade biológica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2344 DE 08/12/2015 |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |